FEBS Letters
Fluorescence‐based CRISPR interference system for controlled genetic repression and live single‐cell imaging in mycobacteria
FEBS Letters, Volume 599, Issue 4, Page 488-501, February 2025.
FEBS Letters
RETRACTION: Theaflavins Retard Human Breast Cancer Cell Migration by Inhibiting NF‐κB via p53‐ROS Cross‐talk
FEBS Letters, Volume 599, Issue 4, Page 596-596, February 2025.
FEBS Letters
Suppression of amber stop codons impairs pathogenicity in Salmonella
FEBS Letters, Volume 599, Issue 4, Page 476-487, February 2025.
FEBS Letters
Correction to: Umbilical cord mesenchymal stem cell‐derived exosomes alleviate collagen‐induced arthritis by balancing the population of Th17 and regulatory T cells
FEBS Letters, Volume 599, Issue 4, Page 592-594, February 2025.
FEBS Letters
Correction to: Gemin5 plays a role in unassembled‐U1 snRNA disposal in SMN‐deficient cells
FEBS Letters, Volume 599, Issue 4, Page 595-595, February 2025.
FEBS Letters
Unraveling membrane protein localization and interactions in nanodiscs
FEBS Letters, Volume 599, Issue 4, Page 512-529, February 2025.
FEBS Letters
ABC transporter activity is affected by the size of lipid nanodiscs
FEBS Letters, Volume 599, Issue 4, Page 502-511, February 2025.
FEBS Letters
Covalent labeling of the Arabidopsis plasma membrane H+‐ATPase reveals 3D conformational changes involving the C‐terminal regulatory domain
FEBS Letters, Volume 599, Issue 4, Page 545-558, February 2025.
FEBS Letters
Disruption of Iqsec1 in mice leads to embryonic lethality with reduced large apical vacuoles in the visceral endoderm
FEBS Letters, Volume 599, Issue 4, Page 581-591, February 2025.